Trial intelligence / Profile preview

Pulmozyme eRapid Nebulizer Study in Cystic Fibrosis

NCT01712334Phase 4Completed

Sponsor
Genentech
Start
Dec 2012
Primary completion
Jun 2013
Modality
Replacement Enzymes
Countries
1
01

Overview

A Phase 4 trial of deoxyribonuclease I in cystic fibrosis (CF), sponsored by Genentech. Started Dec 2012; status: completed.

02

Drugs

deoxyribonuclease I
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT01712334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01712334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call